124 related articles for article (PubMed ID: 21718288)
21. High constitutive activity and a G-protein-independent high-affinity state of the human histamine H(4)-receptor.
Schneider EH; Schnell D; Papa D; Seifert R
Biochemistry; 2009 Feb; 48(6):1424-38. PubMed ID: 19166345
[TBL] [Abstract][Full Text] [Related]
22. Establishment of recombinant cannabinoid receptor assays and characterization of several natural and synthetic ligands.
Geiger S; Nickl K; Schneider EH; Seifert R; Heilmann J
Naunyn Schmiedebergs Arch Pharmacol; 2010 Aug; 382(2):177-91. PubMed ID: 20617431
[TBL] [Abstract][Full Text] [Related]
23. RGS-insensitive G-protein mutations to study the role of endogenous RGS proteins.
Fu Y; Zhong H; Nanamori M; Mortensen RM; Huang X; Lan K; Neubig RR
Methods Enzymol; 2004; 389():229-43. PubMed ID: 15313569
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of action and structural requirements of constrained peptide inhibitors of RGS proteins.
Roof RA; Jin Y; Roman DL; Sunahara RK; Ishii M; Mosberg HI; Neubig RR
Chem Biol Drug Des; 2006 Apr; 67(4):266-74. PubMed ID: 16629824
[TBL] [Abstract][Full Text] [Related]
25. Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay.
Roman DL; Talbot JN; Roof RA; Sunahara RK; Traynor JR; Neubig RR
Mol Pharmacol; 2007 Jan; 71(1):169-75. PubMed ID: 17012620
[TBL] [Abstract][Full Text] [Related]
26. RGS14 is a novel Rap effector that preferentially regulates the GTPase activity of galphao.
Traver S; Bidot C; Spassky N; Baltauss T; De Tand MF; Thomas JL; Zalc B; Janoueix-Lerosey I; Gunzburg JD
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):19-29. PubMed ID: 10926822
[TBL] [Abstract][Full Text] [Related]
27. Identification of peptides that inhibit regulator of G protein signaling 4 function.
Wang Y; Lee Y; Zhang J; Young KH
Pharmacology; 2008; 82(2):97-104. PubMed ID: 18547979
[TBL] [Abstract][Full Text] [Related]
28. Single-cell imaging of intracellular Ca2+ and phospholipase C activity reveals that RGS 2, 3, and 4 differentially regulate signaling via the Galphaq/11-linked muscarinic M3 receptor.
Tovey SC; Willars GB
Mol Pharmacol; 2004 Dec; 66(6):1453-64. PubMed ID: 15383626
[TBL] [Abstract][Full Text] [Related]
29. Lack of receptor-selective effects of either RGS2, RGS3 or RGS4 on muscarinic M3- and gonadotropin-releasing hormone receptor-mediated signalling through G alpha q/11.
Karakoula A; Tovey SC; Brighton PJ; Willars GB
Eur J Pharmacol; 2008 Jun; 587(1-3):16-24. PubMed ID: 18457830
[TBL] [Abstract][Full Text] [Related]
30. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
[TBL] [Abstract][Full Text] [Related]
31. Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms.
Snook LA; Milligan G; Kieffer BL; Massotte D
J Neurochem; 2008 May; 105(3):865-73. PubMed ID: 18182056
[TBL] [Abstract][Full Text] [Related]
32. Regulators of G protein signaling proteins as central components of G protein-coupled receptor signaling complexes.
McCoy KL; Hepler JR
Prog Mol Biol Transl Sci; 2009; 86():49-74. PubMed ID: 20374713
[TBL] [Abstract][Full Text] [Related]
33. Multi-tasking RGS proteins in the heart: the next therapeutic target?
Riddle EL; Schwartzman RA; Bond M; Insel PA
Circ Res; 2005 Mar; 96(4):401-11. PubMed ID: 15746448
[TBL] [Abstract][Full Text] [Related]
34. Analysis of chimeric RGS proteins in yeast for the functional evaluation of protein domains and their potential use in drug target validation.
Ajit SK; Young KH
Cell Signal; 2005 Jul; 17(7):817-25. PubMed ID: 15763424
[TBL] [Abstract][Full Text] [Related]
35. Allosteric inhibition of the regulator of G protein signaling-Galpha protein-protein interaction by CCG-4986.
Roman DL; Blazer LL; Monroy CA; Neubig RR
Mol Pharmacol; 2010 Sep; 78(3):360-5. PubMed ID: 20530129
[TBL] [Abstract][Full Text] [Related]
36. Functional reconstitution of the human chemokine receptor CXCR4 with G(i)/G (o)-proteins in Sf9 insect cells.
Kleemann P; Papa D; Vigil-Cruz S; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2008 Sep; 378(3):261-74. PubMed ID: 18523757
[TBL] [Abstract][Full Text] [Related]
37. Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling.
Leontiadis LJ; Papakonstantinou MP; Georgoussi Z
Cell Signal; 2009 Jul; 21(7):1218-28. PubMed ID: 19324084
[TBL] [Abstract][Full Text] [Related]
38. New roles for Galpha and RGS proteins: communication continues despite pulling sisters apart.
Wilkie TM; Kinch L
Curr Biol; 2005 Oct; 15(20):R843-54. PubMed ID: 16243026
[TBL] [Abstract][Full Text] [Related]
39. RGS3 and RGS4 are GTPase activating proteins in the heart.
Zhang S; Watson N; Zahner J; Rottman JN; Blumer KJ; Muslin AJ
J Mol Cell Cardiol; 1998 Feb; 30(2):269-76. PubMed ID: 9515003
[TBL] [Abstract][Full Text] [Related]
40. Rapid kinetics of regulator of G-protein signaling (RGS)-mediated Galphai and Galphao deactivation. Galpha specificity of RGS4 AND RGS7.
Lan KL; Zhong H; Nanamori M; Neubig RR
J Biol Chem; 2000 Oct; 275(43):33497-503. PubMed ID: 10942773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
